Delivery Order SPE2DB22D3301-SPE2DB25FY7FF
Award Date
7/2/25
Potential Completion Date
7/24/25
Potential Value
$6.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,129.80, was granted by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on December 9, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA, valued at $999,999,999 and running through November 2026. The award covers the delivery of COVID-19 vaccines, specifically Pfizer's COVID-19 vaccine, for the 2024-2025 timeframe. The...
This federal contract award, valued at $6,600.90, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a Delivery Order contract for the delivery of Pfizer COVID-19 vaccine doses during the 2024-2025 period, under the Emergency Use Authorization (EUA). The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant...
This federal contract award is a delivery order valued at $1,129.80 issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the procurement of 0.9ML doses of the Pfizer COVID-19 vaccine for the 2024-2025 period, under the Emergency Use Authorization (EUA). The contract has an ultimate completion date of January 3, 2025 and is a firm fixed-price arrangement. This delivery order is part...
This federal contract award, valued at $6,600.90, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies...
This federal contract award is for the delivery of Pfizer's COVID-19 vaccine during the 2024-2025 timeframe, with a contract ceiling value of $1,100.15. The contract is a Firm Fixed Price Delivery Order awarded by the Defense Logistics Agency (DLA), a defense agency. The awardee is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is not set aside and allows for the delivery of 0.9ML vaccine doses over a period of 4 years, with a...
This federal contract award, valued at $1,100.15, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Pfizer COVID-19 vaccines from 2024 to 2025. The contract is a Firm Fixed Price Delivery Order with a completion date of May 21, 2025. This award is not set-aside and is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with DLA Troop Support Medical, valued at $999,999,999.00, which...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 0.9 ML doses of the Pfizer COVID-19 vaccine for the 2024-2025 timeframe, including the Emergency Use Authorization (EUA) period. The contract has a ceiling value of $1,100.15 and is a Firm Fixed Price Delivery Order with a period of performance through March 26, 2025. The contract is...
This federal contract award, valued at $1,100.15, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Pfizer COVID-19 vaccine doses, with a period of performance from May 2024 to May 2025. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,778.80 firm fixed-price delivery order is for the procurement of Pfizer COVID-19 vaccine doses for the 2024-2025 time period, under an existing Indefinite Delivery Contract (IDC) valued at $999,999,999 that runs through November 2026. This IDC serves as the primary vehicle for AmerisourceBergen to provide a...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $2,778.54 Firm Fixed Price Delivery Order is for the supply of Pfizer COVID-19 vaccine doses (0.9 ML) for the years 2024-2025 under the Food and Drug Administration's Emergency Use Authorization (EUA). The contract has an ultimate completion date of September 20, 2024. This award is not designated as a set-aside contract. AmerisourceBergen holds...